676607-30-0 Usage
Molecular structure
A spirocyclic compound containing an indoline ring fused to a piperidine ring, with one benzyl and one tert-butyl group attached to the nitrogen atoms.
Potential pharmaceutical applications
The compound may have potential as a drug delivery system or as a prodrug due to the presence of the dicarboxylate moiety, which can be hydrolyzed to release the active pharmaceutical ingredient.
Biological activity
The unique structural features of the spirocyclic ring system may contribute to the compound's biological activity, which warrants further research and development.
Novel drug candidates
Further investigation of 1'-benzyl 1-tert-butyl spiro[indoline-3,4'-piperidine]-1,1'-dicarboxylate could lead to the discovery of new drug candidates with therapeutic benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 676607-30-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,6,0 and 7 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 676607-30:
(8*6)+(7*7)+(6*6)+(5*6)+(4*0)+(3*7)+(2*3)+(1*0)=190
190 % 10 = 0
So 676607-30-0 is a valid CAS Registry Number.
676607-30-0Relevant articles and documents
NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
-
, (2019/05/16)
Provided are 2-(piperidin-1-yl)pyrimidin-4(3H)-ones or pharmaceutically acceptable salts thereof, each characterized by having a 1,8-diazaspiro[4.5]deca-3-ene, 1-oxa-8-azaspiro[4.5]deca-3-ene, 2,8-diazaspiro[4.5]deca-3-ene, 2-oxa-8-azaspiro[4.5]deca-3-ene, 2,9-diazaspiro[5.5]undeca-3-ene, 1-oxa-9-azaspiro[5.5]undeca-3-ene, 1,9-diazaspiro[5.5]undeca-4-ene, or 3,9-diazaspiro[5.5]undeca-1-ene structure represented by the following general formula (1):
